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RESUMEN 
La Farmacia Comunitaria forma parte del sistema de salud. Este sistema actualmente se encuentra 
sometido a presiones económicas y debe afrontar cambios en la demanda tanto de los consumidores 
como de los gobiernos. La respuesta de la profesión farmacéutica está dirigida a orientar su práctica 
hacia el paciente y a implantar servicios cognitivos farmacéuticos (CPS). En distintos países estos 
servicios tiene objetivos similares aunque presentan diferencias en el énfasis de los servicios, en sus 
definiciones, denominaciones y en la utilización de diferentes herramientas. Sin embargo, todos ellos 
pueden clasificarse utilizando un amplio modelo jerárquico que se basa en la toma de decisiones 
clínicas y en la amplitud del cambio requerido. (Box 1). Los retos que debe afrontar la profesión están 
relacionados con el desarrollo de un nuevo modelo de farmacia orientado al paciente que afecta  a las 
políticas de salud, a la formación e investigación, a la evolución de los mercados, a los abordajes del 
cambio tanto  a nivel individual como organizacional, y a la implantación de CPS. Estos temas y la 
investigación en práctica farmacéutica que se ha venido realizando con anterioridad han sido 
sintetizados para  proporcionar una plataforma para el cambio que pueda guiar un planteamiento 
holístico e integrado de implantación de CPS. Conceptualmente la implantación de CPS puede 
enmarcarse en seis niveles: clínico, provisión de servicios, farmacia comunitaria, organización 
profesional, gobierno y agentes implicados (Figura 1). La experiencia reciente relacionada con la 
implantación de servicios ha mostrado la aplicación de programas de implantación que han incluido 
uno o dos de estos niveles en lugar de haber utilizado un abordaje holístico. Por ello se ha desarrollado 
un modelo concéntrico para ilustrar la implantación de CPS dentro del planteamiento integrado y 
holístico necesario para apoyar el cambio En España se ha desarrollado un programa (conSIGUE) que 
pretende integrar los seis niveles con el objetivo de apoyar la implantación y evaluación de un CPS, el 
servicio de seguimiento farmacoterapéutico. 
PALABRAS CLAVE: Implantación. Servicios cognitivos farmacéuticos. Farmacia 
comunitaria. Gestión del cambio 
ABSTRACT 
Community pharmacy is part of the health care system which is currently under economic pressure 
and facing changes in demands from consumers and government.  In response, the pharmacy 
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profession is becoming more patient orientated and implementing cognitive pharmaceutical services 
(CPS). CPS in various countries has similar objectives with different emphasis, definitions, labels and 
using different tools. However, they can be classified using a broad hierarchical model based on 
clinical decision making and the extent of change required (Box 1).  The challenges faced by the 
profession are related the development of a new patient orientated model of pharmacy which affects 
health care policy, education and research, the evolution of the market, the individual and 
organisational approaches to change and the implementation of CPS. These issues and previous 
research conducted in pharmacy practice have been synthesised to provide a platform for change that 
can guide a holistic and integrated approach to CPS implementation. Implementation can be 
conceptually framed in six levels: clinical, service provision, community pharmacy, professional 
organisation, government and stakeholder (Figure 1). Past experience with service implementation has 
seen the application of programs that include one or two of these levels in practice rather than a 
holistic approach. A concentric model was developed to illustrate the implementation of CPS and the 
holistic and integrated approach required to support change. A program (conSIGUE) being conducted 
in Spain has attempted to integrate all six levels to support the implementation and evaluation of a 
medication management service (Seguimiento Farmacoterapéutico)  
 
KEYWORDS: Implementation. Cognitive pharmaceutical services. Community pharmacy. 
Change management. 
  
INTRODUCTION 
Community pharmacy is part of the health care system which is currently under economic 
pressure and facing changes in demands from consumers and government.1,2  The pharmacy 
profession is changing to become more patient orientated and to introduce health services in 
an effort to optimise the use of medications and reduce the morbidity and mortality related to 
therapeutic regimens.  
The current challenges facing health care are made more complex by issues such as the 
ageing population, new technologies, transmission of communicable diseases, consumer 
expectations, the increasing burden of chronic conditions and increasing costs.3 Additionally, 
health and drug related problems are often associated with the suboptimal use of medications; 
both prescribed and self-administered.4 As governments are facing increasing demand from 
many competing sources, expenditure dedicated to health care is under scrutiny and there are 
limited funds allocated to address changing needs. Hence, new methods of health care 
provision are required.3 Suggested solutions include the redesign of entire health care 
systems, the creation of multi-disciplinary teams to provide health services and the use of 
technology to create efficiencies in the system.5,6 Additionally, community pharmacy has 
been recognised as an underutilised resource. To ease the burden on existing systems in some 
countries, the professional pharmacy organisations, government and consumers have 
encouraged the profession to introduce health services, or cognitive pharmaceutical services 
(CPS), into daily practice. 7   
CPS in various countries has similar objectives with different emphasis, definitions, labels 
and using different tools. However, they can be classified using a broad hierarchical model 
based on clinical decision making and the extent of change required (Box 1). For example, the 
provision of medicines information could be said to require less clinical decision making as 
compared to prescribing. Similarly, the model attempts to order the degree of change required 
BENRIMOJ SL et al.  Un enfoque holístico e integrado de la implantación de los servicios…            71 
Ars Pharm, 2010, 51-2; 69-87. 
 
from the pharmacist’s traditional role and practice environment to provide services. The 
model has limitations in its capacity to categorise product based services. For example, dose 
administration aids (DAA) may be considered to be enablers for adherence and thus may be 
part of compliance service.  
 
Box 1: Hierarchical Model of Cognitive pharmaceutical services 
 
1. Medicines Information8 
2. Compliance, Adherence and/or Concordance9  
3. Disease Screening10 
4. Disease Prevention11 
5. Clinical Intervention or identification and resolving Drug Related Problems12 
6.  Medication Use Reviews13 
7. Medication management/medication therapy management14-16 
a. Home Medication Reviews 
b. Residential Care Home Medication Reviews 
c. Medication reviews with continuance follow up 
8. Disease State Management for Chronic Conditions17 
9. Participation in therapeutic decisions with Medical Practitioners18,19 
a. In Clinical setting 
b. In the pharmacy 
10. Prescribing20 
a. Supplementary  
b. Dependent 
 
CHALLENGES OF CHANGE IN PHARMACY 
Within the profession, change is politically supported. It is supported by international and 
national professional pharmacy associations through the development of the community 
pharmacist’s role. Patients recognise the benefits of CPS, as illustrated by their insistence in 
receiving patient information. CPS provision aids government achieves a quality use of 
medicines and their cost reduction agenda. Community pharmacists have been able to 
decrease health care expenditure and decrease morbidity rates by preventing drug related 
problems through the provision of CPS.13 The benefit of a change in pharmacy has been 
acknowledged through the adoption of initiatives by governments and more recently by the 
health insurance companies and pharmaceutical companies.21,22 These initiatives have been 
largely based on providing remuneration for CPS to stimulate service provision. There is a 
clear growing trend to remunerate CPS in countries such as United Kingdom, United States of 
America, Australia, Belgium, Switzerland and Portugal, demonstrating that government 
policy has provided support a patient orientated model of pharmacy.7,23,21,24,25  
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The integration of CPS into the daily practice of a community pharmacy produces a 
dilemma resulting from the nature of its operating environment. In practice, the community 
pharmacy operating environment is not exclusively health care or patient focused; the retail 
context of community pharmacy presents a unique challenge.26-28 It merges the commercial 
necessity to run a financially viable and accountable business with the need to configure 
operations to meet appropriate standards of professional conduct and competence.29  
Economic, regulatory and organizational frameworks influence the role of community 
pharmacists through setting standards and commercial limitations of pharmacies as a health 
care retailer.28 Change for community pharmacy implicates interaction with external 
stakeholders (e.g. government bodies, consumers, universities, pharmaceutical industry and 
influencing parties). 
HEALTH CARE POLICY IMPLICATIONS 
In relation to community pharmacy, national governments have used two key strategies to 
manage health policy and expenditure, regardless of country or prevailing political party.30 
These policies control health care costs through the reduction in medication mark-ups, 
margins and reference pricing as well as the flow on effects from the increased use of 
generics.31 Secondly, following WHO policy initiatives, national governments have begun 
integrating quality use (QUM) and/or rational use of medicines (RUM) principles into their 
health agendas.3 The QUM and RUM policies directly and indirectly support the new patient 
orientated model.3,7,32 Some governments recognise CPS provision as a cost effective 
medication management tool, which increases quality of life and reduces morbidity and 
mortality in targeted high cost and other patient populations such as poly-pharmacy 
residential care and geriatric ambulatory patients.14 Government policy also encourages 
chronic disease management particularly through the increased use of multi disciplinary 
teams.5,33  
All health care services can be classified through a spectrum: prevention, early detection, 
diagnosis and assessment, treatment, rehabilitation and palliation.28 In moving through this 
spectrum to identify new opportunities for community pharmacy, a balance must be struck 
between expanding the role of pharmacists and crossing traditional role boundaries, although 
these boundaries are increasingly being questioned. Professional collaboration within the 
health care system is ideal but the increased sense of competition and working outside the 
pre-existing definitions of professional roles have caused tension between pharmacists and 
other groups, such as physicians. In an attempt to overcome these issues, professional 
associations are pursuing collaborative agreements at a political level and individual 
pharmacists are working with their local health care partners.19,34  
EDUCATION AND RESEARCH 
In the area of education, the introduction of CPS has stimulated universities to various 
levels of action. Initially, curriculums were revised for undergraduate and postgraduate 
courses to educate students in these areas and a concurrent development of pharmacy practice 
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research began.35,36 The more sophisticated changes such as joint teaching with other 
professions to provide the foundation for future collaborative working environments have not 
yet been developed sufficiently in most countries.37 It could be suggested that the growth of 
pharmacy practice research has given academic opinion leaders the ability to influence 
changes in professional practice and emphasised evidence based change. Research and 
teaching has been stimulated through the appointment of professors and academic staff 
dedicated to pharmacy practice.38,39 In many countries, this was followed by the creation of 
the discipline of pharmacy practice or/and departments with similar objectives and varied 
titles.38 Pharmacy practice has tended to be the overall arching discipline incorporating 
clinical, administrative and social pharmacy, behavioral studies, pharmaco-epidemiology, 
health economics, marketing and management.  The rate and pace of adoption of this 
educational and research change has varied between and within countries.  It could be said 
that the American and Anglo Saxon university models have changed more rapidly while some 
European universities have been slower. In Europe, the Bologna declaration has stimulated 
debate and resulted in some changes.40,41 However within countries there are examples where 
the change has been rapidly adopted. The negative impact of the slower adoption of 
educational change is evidenced when pharmacists enter the workforce unprepared to provide 
CPS. 
DEVELOPMENT OF THE MARKET 
The pace of change created by government policy, professional organisations and 
universities has challenged community pharmacies and pharmacists to evolve and maintain 
their relevance in the market.26,42 Community pharmacies changing to a patient orientated 
model requires management and structural changes to the business. 26,27,42,43 At the same time 
community pharmacy viability has been put at risk because of the reduced profit margin in 
their traditional core business – dispensing medication and the perception that the return on 
investment of services is low.26,42,44  Some pharmacies have moved toward creating a position 
in the market based on providing CPS while an alternative market segment  is focused on 
convenience and deep discounting in product provision.28,44,45 Currently, the pharmacy market 
is differentiating into these two broad segments. The principles of market differentiation 
suggest that all organisations in an industry cannot provide identical services, eliminating the 
competition in the market.46 In the “so called” liberalised markets of the United Kingdom, 
Canada, Iceland, Norway and United States, corporatized pharmacies are more common with 
few independently owned community pharmacies.7 Larger, supermarket style pharmacies 
with a product/retailing orientation are prevalent. Other countries with a regulated market, 
such as Australia, Spain, France and Italy, are dominated by smaller, independent 
pharmacies.40 In some of these markets, the opportunity for the emerging, service orientated 
model of pharmacy is being closely pursued to compete with the product/retail model.44  
ADDRESSING CHANGE 
Change in community pharmacy has traditionally been addressed in two ways. Firstly, an 
individual practitioner’s point of view has been taken using change theories and strategies 
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largely focused on their behavioural change.47,48Secondly, recent research has focused on the 
organisational level analysis in addition to the individual perspective.49,50 Some of this 
research has used management theories to analyse service integration in practice and promote 
CPS implementation and sustainability.42,45   Furthermore an innovative Australian study 
focused on building capacity in community pharmacy used the framework of organisational 
flexibility (OF) to research CPS implementation.27,44 OF is a key business objective to 
improve viability in a changing environment.51  The concept originally referred to the 
capacity of organisations to proactively and successfully adapt in a dynamic environment.52 
Volberda defined OF as “the degree to which an organisation has a variety of managerial 
capabilities and the speed at which they can be activated, to increase the control capacity of 
management and improve the controllability of the organisation”.53 Feletto et al applied OF to 
community pharmacies using a pre-existing scale to measure the type of flexibility in 
organisations.54 The study illustrated the benefit of applying management frameworks to 
community pharmacy, identified capacity building and strategic decision making by 
pharmacy owners as critical factors to enable and sustain implementation of CPS.54  
IMPLEMENTATION 
Service implementation is complex and represents an area in which community pharmacy 
has had limited past experience. Pharmacists have expressed the need for more assistance in 
guiding the implementation of services.27,28 Evidence has shown that CPS provision can result 
in a viable pharmacy practice, nonetheless the perception by pharmacy owners that this 
viability cannot be sustained in the long term has hindered service implementation. 27,42,44 
There is an existing reliance on dispensing medications as the key source of income supports 
the product orientated model. The challenges in optimising viability through CPS provision 
include payment for services to reduce community pharmacy reliance to product supply and 
validating any cost to patients and/or third party payers.42 There has been criticism of the lack 
of implementation even when payment has been available for service provision. Much of this 
lack of implemenatation has been attributed to practitioners. However, an alternative 
hypothesis may be that there has not been a profession-wide, holistic integrated approach 
specific to pharmacists who wish to  adopt CPS.42 The holistic integrated approach would 
incorporate all significant factors and aid in capacity building of pharmacy owners and 
pharmacy practitioners.27,55  
Therefore the objective of this article is to provide a platform for change that can guide this 
holistic and integrated approach to service implementation in the profession. 
HOLISTIC AND INTEGRATED MODEL 
The issues outlined above, combined with evidence from pharmacy practice research 
identified six key levels of change encapsulated in a holistic approach to implementation of 
services in community pharmacy (Figure 1). This approach is based on an analysis of 
historical developments, practice experience and evidence based research.  
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Figure 1: Holistic approach to service implementation 
 
 
CLINICAL LEVEL 
The initial response by professional organisations and universities to CPS was to develop 
initiatives to improve the clinical competencies of community pharmacist.35,36  Clinical 
practice is the foundation of pharmacy practice and is supported through continued 
development of pharmacists’ clinical skills and competencies.35 The focus of clinical practice 
is to improve patients’ health outcomes, optimise pharmacist-patient relationship and increase 
collaboration with other health care professionals.56 The first reaction by universities and 
professional organisations to change was to offer clinical modules modeled on medical 
courses and mainly concentrating on disease states and medications. Later development 
included the addition of case studies in these programs to have a greater emphasis on practical 
application.36 During this phase, research began to focus on interventions leading to 
behavioural changes that impact on patient consultations and on change to the attitude and 
perceptions of individual pharmacists.47  Although it made logical sense to increase the 
clinical competency of individual pharmacists and increase patient contact it became evident 
that CPS implementation would not be sustainable without additional enablers. In some 
countries, proactive practitioners commenced providing services but these were inconsistent. 
Much of the research at this time began to identify barriers with payment for services 
identified as a major issue.57-59  
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SERVICE PROVISION LEVEL 
In 1990 Hepler and Strand, with the publishing of the conceptual paper on Pharmaceutical 
Care had an impact on the profession worldwide.  However, the concept had to be translated 
to service provision at the community level.2 Following, research based on evaluation of the 
impact of CPS produced with a major objective of defining specific services, classification 
systems, and methodologies, evaluating the clinical, economic and humanistic impact and 
generating data to negotiate service payments.13,15,17 Services and educational programs were 
designed for medication management and reviews, chronic disease states, such as asthma and 
diabetes. Studies provided clear and useful guidelines for the application of the clinical 
knowledge to practice through service provision frameworks. The implementation of services 
was slower than anticipated and sparked further research to uncover the barriers to service 
implementation.60-62 The major barriers cited, reinforcing previous findings, were the time 
involved and lack of remuneration for service delivery.60-62 Research into facilitators of 
practice change began to undertaken. At the professional organisation level it was thought that 
if payment was provided, and coupled with clinical competence, implementation would be 
inevitable. In hindsight this level overlooked the context of the environment in which the 
service was being undertaken, that a pharmacy is a business needing to maintain its viability.  
COMMUNITY PHARMACY LEVEL 
The limited implementation in practice then stimulated work which considered community 
pharmacies as individual organisations with competing objectives of providing health care 
and maintaining their viability.26,28,42 Research was conducted to identify the facilitators of 
implementation to understand how services could be more effectively adopted.63 This 
research identified new barriers and facilitators which helped to better understand and target 
activities to promote the uptake of services.60,61,63 Factors were identified that included 
specific management skills such as delegating and leading, managing staff, internal 
communication, pharmacy layout, enhancing external stakeholder relationship, managing 
consumer expectation and marketing.60,61,63 An important concept was the growing 
acceptance of professional organisations that payment for service delivery was essential but 
not the sole critical factor for implementation.42,61,64 Sustainable delivery of services would 
require fundamental changes to daily professional and business practices and practice change 
needed to integrate the business and health care elements of community pharmacy.42,65 
PROFESSIONAL ORGANISATION LEVEL 
Implementing business and professional aspects requires change in community pharmacies 
and support from professional pharmacy organisations.27,61 Professional organisations can be 
divided into two types, those that represent the professional role of pharmacists and those that 
represent their business requirements.  In some countries there are organisations that merge 
these two interests, but these are generally dominated by pharmacy owners.  In some cases 
this could be the cause of the limited integration of professional and business issues. These 
organisations often compete to provide support services required by pharmacists in practice, 
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which consequently results in a delay in the provision of the necessary support.27,28 
Professional organisations need significant changes to organisational policies, resources and 
internal infrastructure. The existing product-based focus and subsequent product based 
remuneration currently supported by the professional organisations needs to be shifted to 
further support CPS provision and a patient orientated model.32,44,55 Alongside the change 
required at the community pharmacy level, it is essential that professional organisations adapt 
their support systems to address the needs of practicing pharmacists.  This implies a change in 
the traditional role of professional organisations from their normal activities to include setting 
professional standards, lobbying with stakeholders, negotiating payment for services and the 
introduction of adequate support systems for pharmacists and pharmacy. This would require 
significant internal reorganisation and restructuring which has not occurred in many 
organisations to date.7,32,66  
Practice based research has begun to incorporate the role of the profession and their 
respective associations in providing support through infrastructure, policy or resources in 
planning for sustainable CPS delivery. Clear strategic initiatives from the profession need to 
be mapped through more extensive empirical research. Few studies have focused on 
providing concrete directions for professional organisations. On the positive side, where 
remuneration for services has existed for more than ten years there is evidence of internal 
restructuring of professional organisations.67 Sustainable changes to a patient focused model 
integrating CPS requires the support from professional organisations.60,61,65 Without this 
support it could be assumed that service implementation will continue to lag. The 
incorporation of the concept of a patient orientated model into the strategic direction of 
professional organisations is a necessary pillar for ensuring the success of CPS 
implementation. 
GOVERNMENT LEVEL 
Professional organisations and individual pharmacists appear to perceive an unwillingness 
of national governments to provide remuneration for CPS. The main role of government is 
seen by pharmacists as being solely associated with cost reduction initiatives and reduction of 
product margins. However, evidence suggests otherwise. A number of governments have 
instigated reforms to the health care systems which directly benefit pharmacy and support 
CPS provision.7,32,66 However, Government’s objective is to ensure appropriate use of 
taxpayer funds.30,22 They require value to be proven before allocating funds to CPS provision 
payments.  In many counties the prerequisite for approving CPS remuneration has been 
rigorous scientific research findings illustrating the cost effectiveness of pharmacists’ clinical 
interventions.22 These finding alone are not always sufficient, CPS must be placed in the 
existing government agenda.68,69 In some cases third parties, such as consumers, have 
pressured governments to remunerate CPS relating to the provision of medication 
information. However, research on the impact of government policy on CPS is sparse.  
Past experience has suggested that payment for services alone is not sufficient to support 
sustainable CPS provision.42 Government can play a wider role in sustainability that goes 
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beyond facilitating a service payment. This includes resource and intellectual support for 
community pharmacy. Some governments have sponsored initiatives that provide quality and 
accreditation frameworks for pharmacy with associated incentives.21,23,41,70 There have been 
financial incentives provided to encourage infrastructure changes and the implementation of 
quality assurance systems.66  
The recognition of community pharmacy as an integral part of the health care system and 
pharmacists as members of the primary health care teams is of great importance to the 
implementation process. There is now the need to cement the role of community pharmacy 
and pharmacists in multi disciplinary disease management teams through government policy. 
Governments do have a role not only in providing financial support for CPS but including 
community pharmacy in health policy. When governments do not act through their own 
initiatives then there should be a desire by pharmacy organisations to lobby. 
STAKEHOLDER LEVEL 
The final and overarching level is the stakeholder level. This level includes representatives 
external to the profession, such as patients, their organisations, and bodies of other health care 
professional groups such as physicians and nurses.71-73 The literature only provides a limited 
analysis on the impact of these bodies on the implementation process and focuses primarily 
on two areas: (1) the use of pharmacies by consumers and/or their level of satisfaction with a 
given service and (2) collaborative efforts between pharmacists and the other health care 
professionals as part of a collective primary health care team, specifically physicians.74,34,75  
The effect of CPS provision to external stakeholders can be illustrated using medication 
management reviews (MMR) with their effect on physicians and patients.19,74,34 A key 
outcome of MMR is an adjustment in the patient’s medication therapy. Without this 
adjustment the review can be said to have limited application. The degree of collaboration 
between the physician and the pharmacist directly influences the success or failure of the 
MMR. This collaboration can be influenced by the interaction between physicians and 
pharmacists at four levels: a national (professional organisation) level, a regional (state or 
provincial) level, a local health care team level (with a group of health care professionals) and 
an individual level in regards to a specific patient. Issues at any of these levels can affect the 
outcome of MMRs. 
In many countries there is open criticism by physicians regarding the provision of CPS. 
Generally, physicians consider pharmacists as lacking the competency to provide CPS. They 
also believe that CPS encroach on the physician’s professional role and are reluctant to share 
confidential clinical information about their patients. Community pharmacies are seen as 
focused on retailing rather than health care, thus motivated by improving their bottom line 
rather than the patient’s health. If left unaddressed, these issues can impede any CPS 
implementation program. A collaborative relationship with local physicians has been 
identified as a key facilitator MMR services.42,61,76  
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In contrast to the opinions held by physicians, patients who have been provided CPS have 
high rates of satisfaction but paradoxically consumer representative organisations are critical 
of the consistency of pharmacy performance.8,77-79  Generally, pharmacy users are unaware of 
CPS and their benefits, thus there is little demand being generated.  As part of the retail 
environment, community pharmacists are highly sensitive to consumer demand and 
expectations and suffer financially if they do not respond to user needs. They are accustomed 
to focus on improving waiting time and pricing to meet user demands but in regards to CPS 
provision they are less proactive.80 Future CPS implementation programs should include 
consumer awareness and internal marketing to promote the service. Overall, the importance of 
external stakeholders should not be underestimated as they provide a valuable external 
stimulus. 
USING THE HOLISTIC AND INTEGRATED APPROACH IN PRACTICE:  
CONSIGUE PROGRAM 
Past experience with service implementation has seen the application of programs that 
include one or two of levels described above rather than a holistic approach. A program 
(conSIGUE) being conducted in Spain has attempted to integrate all six levels to support the 
implementation and evaluation of a medication management service (Seguimiento 
Farmacoterapéutico). The overall aim of conSIGUE is to evaluate the clinical, economic and 
humanistic impact of the provision SFT in the community pharmacy in the elderly poly-
pharmacy population. 
The program began with a series of consultations with professional organisations and 
stakeholders to ensure that the program objectives were aligned to the key government 
objectives in Spain. As in many other countries, the Spanish elderly poly-pharmacy 
population is a group placing high demand on the health care system because of their complex 
medication regimens and co morbidities.81 The Spanish government considers this group as a 
priority in their strategic health plans for the future.82 The government and, the major 
pharmacy professional association, such as the Consejo General de Colegios Oficiales de 
Farmacéuticos (CGCOF), have supported the delivery of medication related services through 
community pharmacies.83 To plan the changing role of pharmacy, a group of leading 
politicians, professional pharmacy associations and non-university and university research 
groups came together and in January 2008 produced a consensus outlining their commitment 
to providing three key CPS through community pharmacies. One of these services is 
Seguimiento Farmacoterapéutico (SFT), a medication management service.84  
A holistic program has been designed to gain support from stakeholders, professional 
organisations and to set up the service effectively in the pharmacies. Led by the University of 
Granada, conSIGUE has obtained support from the Government, CGCOF, medical 
organisations and other Spanish universities for the implementation of SFT in Spanish 
community pharmacies. The program is being conducted in selected provinces across the 
country and supported by the local pharmacy organisations. In addition to their collaboration, 
the program aims to stimulate structural and strategic change in these organisations to 
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incorporate CPS provision in the long term.  
Together with the Consejo and local organisations, the autonomous communities 
(provincial government) in participating provinces have been contacted to encourage their 
cooperation. Government financial and structural support is essential to the success of the 
program in the long term. Medical organisations have also been approached at national and 
provincial levels to explain SFT and the benefits of this service to the medical profession and 
patients to encourage collaboration. Additionally, local health care team and individual 
collaboration with physicians is occurring, with meetings being held by individual 
pharmacists participating in the program. A national advisory committee to guide the program 
has been created, as well as advisory committees in each participating provinces, which 
include representatives from consumer groups, physician associations, political groups, 
universities and pharmacy associations.  
The program consists of training for participating pharmacists that cover the six levels and 
critically on-site support throughout the program. The training program has been designed in 
four parts and is provided to pharmacists over a series of days by a group of experts (Figure 
2).  
Figure 2: conSIGUE – Holistic training program 
 
 
Part 1 outlines the Spanish political environment that has resulted in the acceptance of SFT 
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as a service to be provided through community pharmacy and the support from various 
professional organizations and political bodies. The purpose of this part is to contextualize the 
need for change as well as acknowledge the support for SFT provision. In this way, it outlines 
the place of SFT within the national health policy and the support of physician representative 
organisations.  
Part 2 guides pharmacists through the strategic options available and highlights how SFT 
integrates into pharmacy business models. The facilitators and organisational needs of 
pharmacies when implementing services found in previous research are discussed. 
Pharmacists are provided with practical action plans to address each issue applicable to their 
pharmacy. The return on investment of SFT provision is also outlined and pharmacists are 
provided with a guide for its calculation.  
Part 3 addresses the process of SFT provision based on the Dader method85 and the clinical 
knowledge required by pharmacists to evaluate the health problems of poly pharmacy in 
elderly patients. The emphasis is placed on teaching the pharmacist the essential elements of 
the process and giving them an overview of the relevant clinical issues they require so they 
can apply it to their patients.  The emphasis is not placed solely on theoretical aspects of the 
process and clinical pharmacy. It includes its practical application using case example that 
pharmacists work through. The SFT service is described in detail. 
Part 4 focuses improving the communication and collaboration between community 
pharmacists, patients and physicians during the process of SFT. Firstly, this looks at the 
pharmacist-patient interaction and the behaviour change required by both to improve SFT 
outcomes. The acceptance of pharmacist-led interventions by physicians has proven difficult 
in the past because of the overlap in professional roles. It is widely acknowledged that 
collaboration between physicians and community pharmacists can be improved to facilitate 
the provision of SFT. Therefore, conSIGUE includes a pharmacist-physician intervention 
aimed at improving their collaboration.  
Research has suggested that pharmacist training needs to be supported by individualised 
assistance over time to encourage CPS implementation and sustainability.27,86 The role of a 
“formador colegial” was developed as part of the program to provide ongoing support to 
participating pharmacists. The “formador colegial” carries out a number of visits to the 
pharmacies to assess their progress with SFT and aid them with any problems they may be 
facing. This addresses the needs of pharmacists related to a number of levels in the holistic 
approach such as collaboration with physicians, patient related issues and clinical knowledge. 
The “formador colegial” performs the role of change agent to support the platform presented 
in Figure 1 and the overall holistic approach.  
CONCLUSION  
A concentric model was developed to illustrate the evolution and implementation of CPS 
and the holistic and integrated approach required to support change. Community pharmacy 
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and pharmacists cannot change without support from the professional, government and 
stakeholder levels. Pharmacy decision makers need to align policy changes and strategic 
thinking with practical applications. There is a need for professional organisation to 
restructure their own internal management systems and support to provide sophisticated 
programs enabling community pharmacists to provide CPS. The lack of support in this area 
may result in the prevalence of product orientated model, which is more retail focused and 
currently more developed than the patient orientated model.  
The foundation for change begins by having a workforce that has the theoretical 
understanding, competency and the skills to practically apply their comprehensive knowledge. 
At the same time, pharmacists need to build their business and management skills to ensure 
that they can operate financial viable businesses. This will enhance CPS sustainability and 
will benefit the patients and society. The responsibility for initiating this change lies in the 
leadership and intellectual role of the universities. The universities have to accept their 
responsibility of being change agents for the profession through a greater relevance of the 
degrees for the profession. University research leadership will ensure that the profession take 
evidence based decisions and that they can be active partners in determining the future of 
pharmacy. The establishments of departments of pharmacy practice, with research capability, 
are necessary. If universities fail to act then the profession will be required to look outside 
faculties of pharmacy for this research.  
Once the foundations are set the responsibility then predominantly transfers to the 
profession where it needs to create a practice and business environment where the patient 
orientated model can prosper. This change can commence through the reorganising and 
restructuring of professional organisations to promote CPS and reduce the dependent of 
product based structures. The organisational change should include a review of its internal 
political processes staffing competencies and structures. Without a change in the professional 
organisations there is a high probability that the product based community pharmacy model 
will increase its influence. Retailing and dispensing of products will be the major activity and 
business of community pharmacy leading to a possible further exclusion of pharmacist from 
the primary health care teams and an inability to serve the primary health care needs of the 
population.  
External stakeholders such as governments, health care providers and patients have 
recognised that medications and CPS are an essential element of the health system.  If 
pharmacists are medication experts and community pharmacy is the model for delivering 
medications and services to optimise their use, a change in the way the current model operates 
is required. The rate and depth of change for the profession is primarily an internal decision 
and challenge. It is through programs such as conSIGUE that the holistic and integrated 
approach can be tested and refined. 
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